SCMF

Yamaha Rehabilitates Popular OHV Area in San Bernardino National Forest

Retrieved on: 
Monday, October 17, 2022
Linda, NRIST Unmanned Helicopters, ATV, News, Motor controller, Hunting, Scooter, SMT, Powersports, Side, San Bernardino National Forest, Motorcycle, Family, Volunteering, SCMF, SxS, Boat, Program, OHV, Plant, Friends, OAI, Yamaha Motor Company, Science and technology in Asia, Social media, GLOBE, Pinnacle, Clothing, Electric motorcycles and scooters, Scottish Outdoor Access Code, Leadership, Risk management, Yamaha Corporation, Snowmobile

Most recently, Yamaha corporate team members joined the Southern California Mountains Foundation (SCMF) to help rehabilitate a frequently utilized OHV area of the San Bernardino National Forest .

Key Points: 
  • Most recently, Yamaha corporate team members joined the Southern California Mountains Foundation (SCMF) to help rehabilitate a frequently utilized OHV area of the San Bernardino National Forest .
  • Thanks to the generous support of Yamahas employee volunteers, we were able to make significant progress in our Pinnacles Staging Area restoration.
  • A group of Yamaha employees, along with family and friends, recently planted more than 300 native species plants around the Pinnacles OHV Staging Area to restore its boundaries and encourage responsible on-trail riding.
  • The Yamaha OAI program encourages riding clubs, land stewardship associations, and public land managers to work together with Yamaha dealers to identify projects and apply for support.

Sydnexis Secures $45 Million Series B Financing Led by Visionary Ventures and Blue Stem Capital

Retrieved on: 
Tuesday, August 10, 2021
Health, Clinical Trials, General Health, Pharmaceutical, Optical, Biotechnology, Biotechnology, Temperature, Life, CEO, LinkedIn, Quality of life, Diagnosis, Lists of people executed in the United States, Efficiency, Risk, Ophthalmology, RA, STAAR, Clinical trial, Health care, Venture, Southern California, SCMF, Center for Epidemiologic Studies Depression Scale, Myopia, Eye, Doctor of Philosophy, Orange County, California, Population, Disease, Investment, CA, Severe cognitive impairment, Pharmaceutical industry, Financial services, Healthcare, Sydnexis, Inc., Visionary Ventures, Bluestem Capital, SC Master Fund, RA Capital Management, Longitude Capital, SYDNEXIS, INC., VISIONARY VENTURES, BLUESTEM CAPITAL, SC MASTER FUND, RA CAPITAL MANAGEMENT, LONGITUDE CAPITAL

Sydnexis, Inc., a clinical stage biopharmaceutical company with a proprietary formulation of low dose atropine for the treatment of progressive myopia, today announced the completion of a $45 million Series B financing led by Visionary Ventures, Blue Stem Capital, and SC Master Fund, with participation from existing investors RA Capital Management, Longitude Capital, and Medicxi.

Key Points: 
  • Sydnexis, Inc., a clinical stage biopharmaceutical company with a proprietary formulation of low dose atropine for the treatment of progressive myopia, today announced the completion of a $45 million Series B financing led by Visionary Ventures, Blue Stem Capital, and SC Master Fund, with participation from existing investors RA Capital Management, Longitude Capital, and Medicxi.
  • Sydnexis STAAR study is the largest pediatric myopia study globally to investigate the use of low dose atropine to retard progressive myopia.
  • In this study, Sydnexis is evaluating two different concentrations of its proprietary atropine formulation SYD-101 (0.01% and 0.03%) versus a placebo control group.
  • With more than 95 years of collective experience, Bluestem Capital is a private equity and venture capital firm currently with 25 portfolio companies.